Longitudinal metric properties of disability rating scales for Parkinson's disease.
暂无分享,去创建一个
[1] A. Stiggelbout,et al. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[2] Kathleenl N. Lohr,et al. Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.
[3] M H Liang,et al. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. , 1985, Arthritis and rheumatism.
[4] P. Behl,et al. Progress in Clinical Neurosciences: Cognitive Markers of Progression in Alzheimer's Disease , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[5] D. Streiner,et al. Health measurement scales , 2008 .
[6] Martin A. Samuels,et al. ADAMS AND VICTOR'S PRINCIPLES OF NEUROLOGY , 2010, Neurology.
[7] Lewis E. Kazis,et al. Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.
[8] Daniel L Riddle,et al. Assessing sensitivity to change: choosing the appropriate change coefficient , 2005, Health and quality of life outcomes.
[9] Gordon H Guyatt,et al. Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.
[10] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[11] P. Martínez-Martín,et al. Intermediate scale for assessment of Parkinson's disease. Characteristics and structure. , 1995, Parkinsonism & related disorders.
[12] A. H. Zwinderman,et al. Rating impairment and disability in Parkinson's disease: Evaluation of the unified Parkinson's disease rating scale , 1994, Movement disorders : official journal of the Movement Disorder Society.
[13] F D Wolinsky,et al. Identifying meaningful intra-individual change standards for health-related quality of life measures. , 2000, Journal of evaluation in clinical practice.
[14] Z. Schwab,et al. Projection technique for evaluating surgery in Parkinson’s disease , 1969 .
[15] G. Regehr,et al. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. , 1997, Journal of clinical epidemiology.
[16] J. Turner. Third Symposium on Parkinson's Disease , 1970 .
[17] A. Thompson,et al. Exploring rating scale responsiveness , 2004, Neurology.
[18] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[19] P. Fayers,et al. Quality of Life: Assessment, Analysis, and Interpretation , 2000 .
[20] Ray Fitzpatrick,et al. Comparing Alternative Rasch-Based Methods vs Raw Scores in Measuring Change in Health , 2004, Medical care.
[21] Ross D Crosby,et al. Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.
[22] K. Marder,et al. Reliability of patient completion of the historical section of the unified Parkinson's disease rating scale , 1996, Movement disorders : official journal of the Movement Disorder Society.
[23] B. Djahanguiri,et al. The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.
[24] C. Terwee,et al. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation , 2003, Quality of Life Research.
[25] Tx Station. Stata Statistical Software: Release 7. , 2001 .
[26] L. Seeberger,et al. Schwab & England: Standardization of administration , 2000, Movement disorders : official journal of the Movement Disorder Society.
[27] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[28] J. Wright,et al. A comparison of different indices of responsiveness. , 1997, Journal of clinical epidemiology.
[29] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[30] D L Riddle,et al. Health status measures: strategies and analytic methods for assessing change scores. , 1996, Physical therapy.
[31] T. Munsat. Quantification of neurologic deficit , 1989 .
[32] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[33] C. McHorney,et al. Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.
[34] P. Lachenbruch. Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .
[35] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[36] D. Gladman,et al. Methods for assessing responsiveness: a critical review and recommendations. , 2000, Journal of clinical epidemiology.
[37] B. Spilker,et al. Quality of life and pharmacoeconomics in clinical trials , 1996 .
[38] J. Molinuevo,et al. Pallidotomy and quality of life in patients with parkinson's disease: An early study , 2000, Movement disorders : official journal of the Movement Disorder Society.
[39] L. Rajmil. Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .
[40] G. Guyatt,et al. Establishing the minimal number of items for a responsive, valid, health-related quality of life instrument. , 2001, Journal of clinical epidemiology.
[41] M J Buxton,et al. Evaluating patient-based outcome measures for use in clinical trials. , 1998, Health technology assessment.
[42] K. Rockwood,et al. Testing the measurement properties of the Short Form-36 Health Survey in a frail elderly population. , 1998, Journal of clinical epidemiology.
[43] D. Bennett,et al. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale , 1997, Neurology.
[44] D. Calne,et al. Assessment of Parkinson's Disease , 1984, Clinical neuropharmacology.
[45] M Richards,et al. Interrater reliability of the unified Parkinson's disease rating scale motor examination , 1994, Movement disorders : official journal of the Movement Disorder Society.
[46] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[47] A M Stiggelbout,et al. A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[48] D. Streiner,et al. Health Measurement Scales: A practical guide to thier development and use , 1989 .
[49] M. Splaine,et al. Use of the Reliable Change Index to evaluate clinical significance in SF-36 outcomes , 2002, Quality of Life Research.
[50] G. Stebbins,et al. Factor structure of the unified Parkinson's disease rating scale: Motor examination section , 1998, Movement disorders : official journal of the Movement Disorder Society.
[51] C. Bombardier,et al. A taxonomy for responsiveness. , 2001, Journal of clinical epidemiology.
[52] J. Molinuevo,et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[53] W. Poewe,et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[54] W M Tierney,et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.
[55] Pablo Martínez-Martín,et al. Patients', doctors', and caregivers' assessment of disability using the UPDRS‐ADL section: Are these ratings interchangeable? , 2003, Movement disorders : official journal of the Movement Disorder Society.
[56] P. Martínez-Martín,et al. Unified Parkinson's disease rating scale characteristics and structure , 1994, Movement disorders : official journal of the Movement Disorder Society.
[57] D. Brooks,et al. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials. , 1997, Clinical neuropharmacology.
[58] R. Hays,et al. Estimating clinically significant differences in quality of life outcomes , 2004, Quality of Life Research.